72 related articles for article (PubMed ID: 21732413)
1. Identification of specific nuclear structural protein alterations in human breast cancer.
Debald M; Franken S; Heukamp LC; Linke A; Wolfgarten M; Walgenbach KJ; Braun M; Rudlowski C; Gieselmann V; Kuhn W; Hartmann G; Walgenbach-Brünagel G
J Cell Biochem; 2011 Nov; 112(11):3176-84. PubMed ID: 21732413
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
[TBL] [Abstract][Full Text] [Related]
3. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
4. Separation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming.
He Q; Zhang SQ; Chu YL; Jia XL; Zhao LH; Wang XL
Acta Oncol; 2010; 49(1):76-84. PubMed ID: 19878069
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
6. Irradiated breast cancer patients demonstrate subgroup-specific regularities in protein expression patterns of circulating leukocytes.
Yeghiazaryan K; Mamlouk S; Trog D; Moenkemann H; Braun M; Kuhn W; Schild H; Golubnitschaja O
Cancer Genomics Proteomics; 2007; 4(6):411-8. PubMed ID: 18204204
[TBL] [Abstract][Full Text] [Related]
7. Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines.
Samuel SK; Minish TM; Davie JR
J Cell Biochem; 1997 Jul; 66(1):9-15. PubMed ID: 9215523
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of endothelial cells in human lung cancer.
Park HJ; Kim BG; Lee SJ; Heo SH; Kim JY; Kwon TH; Lee EB; Ryoo HM; Cho JY
J Proteome Res; 2008 Mar; 7(3):1138-50. PubMed ID: 18220333
[TBL] [Abstract][Full Text] [Related]
9. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
10. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
11. Nuclear matrix proteins in normal and breast cancer cells.
Khanuja PS; Lehr JE; Soule HD; Gehani SK; Noto AC; Choudhury S; Chen R; Pienta KJ
Cancer Res; 1993 Jul; 53(14):3394-8. PubMed ID: 8324750
[TBL] [Abstract][Full Text] [Related]
12. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
13. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer.
Alvarez-Chaver P; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; Páez de la Cadena M
Int J Biochem Cell Biol; 2007; 39(3):529-40. PubMed ID: 17084656
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line.
Rubporn A; Srisomsap C; Subhasitanont P; Chokchaichamnankit D; Chiablaem K; Svasti J; Sangvanich P
Cancer Genomics Proteomics; 2009; 6(4):229-37. PubMed ID: 19657000
[TBL] [Abstract][Full Text] [Related]
15. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
16. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
[TBL] [Abstract][Full Text] [Related]
18. Identification of nuclear matrix protein alterations associated with human colon cancer.
Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH
Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of acidic proteins with progression in the MCF10 model of human breast disease.
Buchanan NS; Zhao J; Zhu K; Patwa TH; Miller FR; Lubman DM
Int J Oncol; 2007 Oct; 31(4):941-9. PubMed ID: 17786328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
